Established in April, 20 15, jiyinga has established medical laboratories, genetic research institutes, medical device industrialization bases and other entities in Beijing, Suzhou and Shenzhen, with more than 1600 employees and a business area of over 33,000 square meters.
Suzhou Jiyinjia Biomedical Engineering Co., Ltd. was established on August 26, 20 16, and the company is located in Suzhou Industrial Park, Jiangsu Province. The company's main business scope is research and development, production and sales of biomedicine and medical devices; Biotechnology development, technical consultation, technology transfer, technical services, etc.
In addition, Suzhou Jiyinjia Biomedical Engineering Co., Ltd. has made a forward-looking layout of the domestic NGS strategy, and based on this, it has built four business segments: clinical testing, medical device manufacturing, scientific and technological cooperation and cancer prevention, and is committed to becoming the most reliable cancer prevention service platform.
Suzhou Jiyinga Company Services:
With the help of NGS manufacturing in China, medical laboratories linked by three places, and cloud computing platform to cooperate with medical production and research, Jiyinga has provided cancer CRO services to more than 60 pharmaceutical companies around the world through the whole chain of prevention and treatment such as precise medication, postoperative monitoring and early screening.
Relying on the company's medical laboratory, Onco series cancer detection products were launched to meet the actual needs of clinical precise medication and full-course monitoring. It has provided clinical testing services to more than 1000 clinical experts in more than 500 hospitals across the country, completed more than 430,000 tumor samples and carried out more than 400 clinical research projects.